140 filings
Page 6 of 7
8-K
kfjf1qpzd e40ws6ay
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
jck7 gm7ci0dx
8 Nov 17
Fibrogen Reports Third Quarter 2017 Financial Results
12:00am
8-K
gj3u1jd6lwsqp o2v5m
1 Nov 17
Astellas and FibroGen Announce Positive Topline Results
12:00am
8-K
ss9bqtx
18 Oct 17
Fibrogen Announces Acceptance by China Fda of Roxadustat New Drug
12:00am
8-K
9b9d7f0648 wj3aj
19 Sep 17
Fibrogen Appoints Gerald Lema to Board of Directors
12:00am
8-K
gacersk
13 Sep 17
Other Events
12:00am
8-K
r8zfo6chw92p ify0
16 Aug 17
Fibrogen, Inc. Announces Pricing Offollow-on Offering of Common Stock
12:00am
8-K
a8ysrq
14 Aug 17
Q2 2017 FibroGen Inc Earnings Call
12:00am
8-K
xqneb8uhax ab26zj2a
7 Aug 17
Fibrogen Reports Second Quarter 2017 Financial Results
12:00am
8-K
n4qw dlg4q8o
9 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
u951 ds3d47grifc30
9 May 17
Fibrogen Reports First Quarter 2017 Financial Results
12:00am
8-K
1kohjzx
6 Apr 17
Fibrogen, Inc. Announces Pricing Offollow-on Offering of Common Stock
12:00am
8-K
pvoa2lu sqmn
31 Mar 17
Fibrogen Announces China Fda Approval of Cta to Conduct Pivotal Phase 2/3 Clinical Trial of Roxadustat In Anemia Associated with Lower Risk MDS
12:00am
8-K
gmorg714xa0a
2 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
gem ohv0d09d778pua7
1 Mar 17
Fibrogen Reports Fiscal 2016 Financial Results
12:00am
8-K
1uk45b
16 Feb 17
Regulation FD Disclosure
12:00am
8-K
2t5zir un
30 Jan 17
Other Events
12:00am
8-K
qdc8br4vxpvh
15 Nov 16
Departure of Directors or Certain Officers
12:00am
8-K
n7ppqofyeau8sun
8 Nov 16
FibroGen Reports Financial Results for the Third Quarter of 2016 and Provides Corporate Update
12:00am
8-K
em14fknj9pq vj
8 Aug 16
FibroGen Reports Financial Results for the Second Quarter of 2016
12:00am